Medico Intercontinental Ltd
Incorporated in 1914, Medico Intercontinental
Ltd is engaged in trading of Pharmaceutical products[1]
- Market Cap ₹ 30.5 Cr.
- Current Price ₹ 30.5
- High / Low ₹ 60.0 / 26.0
- Stock P/E 13.7
- Book Value ₹ 39.8
- Dividend Yield 0.00 %
- ROCE 9.56 %
- ROE 6.90 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.77 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 6.61% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Services Services Commercial Services & Supplies Trading & Distributors
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.02 | 0.27 | 0.23 | 2.03 | 0.00 | 9.95 | 46.93 | 41.02 | 39.25 | 48.88 | 44.04 | 67.13 | 52.56 | |
| 0.00 | 0.27 | 0.32 | 1.97 | 0.34 | 9.27 | 44.73 | 38.68 | 36.98 | 46.38 | 41.44 | 62.83 | 48.66 | |
| Operating Profit | 0.02 | 0.00 | -0.09 | 0.06 | -0.34 | 0.68 | 2.20 | 2.34 | 2.27 | 2.50 | 2.60 | 4.30 | 3.90 |
| OPM % | 100.00% | 0.00% | -39.13% | 2.96% | 6.83% | 4.69% | 5.70% | 5.78% | 5.11% | 5.90% | 6.41% | 7.42% | |
| 0.00 | 0.00 | 0.00 | -0.05 | 0.39 | 0.36 | 0.02 | 0.16 | 0.18 | 0.34 | 0.42 | 0.50 | 1.12 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.66 | 0.78 | 0.52 | 0.37 | 0.22 | 0.67 | 1.29 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.06 | 0.10 | 0.09 | 0.18 | 0.56 | 0.75 |
| Profit before tax | 0.02 | 0.00 | -0.09 | 0.01 | 0.05 | 1.03 | 1.54 | 1.66 | 1.83 | 2.38 | 2.62 | 3.57 | 2.98 |
| Tax % | 50.00% | -33.33% | 0.00% | 40.00% | 26.21% | 27.27% | 27.71% | 28.42% | 28.15% | 27.48% | 28.29% | ||
| 0.01 | 0.00 | -0.06 | 0.01 | 0.03 | 0.76 | 1.12 | 1.20 | 1.31 | 1.70 | 1.90 | 2.57 | 2.23 | |
| EPS in Rs | 0.40 | 0.00 | -0.18 | 0.03 | 0.09 | 2.34 | 3.45 | 3.69 | 4.03 | 1.70 | 1.90 | 2.57 | 2.23 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 5.88% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 74% |
| 5 Years: | 7% |
| 3 Years: | 20% |
| TTM: | -9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 18% |
| 3 Years: | 25% |
| TTM: | -9% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -10% |
| 3 Years: | -26% |
| 1 Year: | -41% |
| Return on Equity | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 8% |
| 3 Years: | 7% |
| Last Year: | 7% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.25 | 3.25 | 3.25 | 3.25 | 3.25 | 3.25 | 3.25 | 3.25 | 3.25 | 10.00 | 10.00 | 10.00 | 10.00 |
| Reserves | 0.04 | 0.04 | -0.02 | -0.01 | 0.02 | 0.78 | 1.90 | 3.09 | 4.40 | 24.30 | 26.10 | 28.66 | 29.81 |
| 0.02 | 0.02 | 0.23 | 0.02 | 0.02 | 0.09 | 8.56 | 4.81 | 6.21 | 2.27 | 0.96 | 13.22 | 13.71 | |
| 0.01 | 0.02 | 0.07 | 0.93 | 0.62 | 5.00 | 5.46 | 5.27 | 3.85 | 7.81 | 2.39 | 6.89 | 2.75 | |
| Total Liabilities | 0.32 | 3.33 | 3.53 | 4.19 | 3.91 | 9.12 | 19.17 | 16.42 | 17.71 | 44.38 | 39.45 | 58.77 | 56.27 |
| 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.12 | 0.24 | 0.20 | 0.48 | 0.33 | 4.39 | 4.39 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 3.57 | 4.35 | 4.20 | 4.20 | 4.20 | 7.19 | 12.55 |
| 0.32 | 3.33 | 3.53 | 4.18 | 3.90 | 9.09 | 15.48 | 11.83 | 13.31 | 39.70 | 34.92 | 47.19 | 39.33 | |
| Total Assets | 0.32 | 3.33 | 3.53 | 4.19 | 3.91 | 9.12 | 19.17 | 16.42 | 17.71 | 44.38 | 39.45 | 58.77 | 56.27 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.96 | 0.12 | -0.04 | 0.02 | 0.95 | -6.55 | 5.44 | 1.10 | -11.95 | 5.73 | -6.78 | ||
| 0.00 | 0.00 | -0.01 | 0.00 | -0.03 | -3.68 | -0.94 | -0.80 | -5.02 | -6.65 | -4.78 | ||
| 3.00 | 0.00 | 0.00 | 0.00 | 0.07 | 9.22 | -4.51 | 0.87 | 20.63 | -1.63 | 10.57 | ||
| Net Cash Flow | 0.04 | 0.12 | -0.05 | 0.02 | 0.99 | -1.01 | -0.02 | 1.17 | 3.66 | -2.54 | -0.99 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 79.35 | 339.83 | 237.34 | 98.54 | 71.45 | 78.86 | 186.08 | 123.74 | 123.81 | |
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | 25.84 | 22.28 | 36.32 | 26.47 | 31.98 | 45.60 | 19.14 | |
| Days Payable | 200.54 | 45.26 | 51.21 | 39.76 | 64.82 | 19.26 | 36.38 | |||||
| Cash Conversion Cycle | 0.00 | 0.00 | 79.35 | 339.83 | 62.63 | 75.57 | 56.56 | 65.57 | 153.24 | 150.08 | 106.56 | |
| Working Capital Days | 4,927.50 | 4,352.96 | 4,760.87 | 345.22 | 78.50 | 76.45 | 56.86 | 63.61 | 154.65 | 141.89 | 155.01 | |
| ROCE % | 6.67% | 0.00% | -2.66% | 1.79% | 1.53% | 28.07% | 24.68% | 19.63% | 18.79% | 10.91% | 7.71% | 9.56% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 15 Nov
- Results - Financial Results For The Quarter And Half Year Ended September 30, 2025 14 Nov
-
Board Meeting Outcome for Outcome Of Board Meeting Held On November 14, 2025
14 Nov - Approved unaudited Q2/H1 results ended 30 Sep 2025: H1 revenue Rs2,670.86L, H1 PAT Rs114.80L.
-
Board Meeting Intimation for Compliance Of Regulation 29, 30 And 33 Of The SEBI (LODR) Regulations, 2015.
6 Nov - Board meeting Nov 14, 2025 to approve unaudited Q2/H1 results (Sept 30, 2025); trading window closed until 48 hours post-declaration.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 9 Oct
Business Overview:[1][2]
MIL (Formerly M/S. Intercontinental Leasing
& Finance Company Limited) was in the textile business. Currently, it trades pharmaceutical products related to Gastro, Uro, Nutrition, Cosmetology, Health Devices, Hospital,
etc.